Expression and methylation analysis of p15 and p16 in mouse bone marrow cells exposed to 1,4-benzoquinone

被引:11
作者
Tian, J-F [1 ]
Peng, C-H [1 ]
Yu, X-Y [1 ]
Yang, X-J [1 ]
Yan, H-T [1 ]
机构
[1] Wenzhou Med Coll, Sch Environm Sci & Publ Hlth, Wenzhou 325035, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
benzene; p15; p16; mRNA expression; methylation; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; BENZENE METABOLITE; CHILDHOOD LEUKEMIA; CANCER; HYDROQUINONE; P15(INK4B); PATTERNS; HISTORY; REPAIR;
D O I
10.1177/0960327111422403
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Benzene is an important industrial chemical. It is also an environmental pollutant recognized as a human carcinogen. Both prenatal and adult exposures to benzene are associated with the development of leukemia. To understand the mechanism of benzene-induced epigenetic variations, we investigated the expression and methylation patterns of CpG (phosphodiester bond between cytosine and guanine) islands in p15 and p16 promoter regions in 1,4-benzoquinone (1,4-BQ)-treated primary cultivated C57BL/6J mouse bone marrow cells in vitro. The cell toxicity of 1,4-BQ was evaluated by cell viability test, real-time PCR was used to measure the mRNA expression levels, and bisulfite sequencing PCR (BSP) was used to look into the methylation patterns. The cell viability test indicates that 1,4-BQ exhibited a dose-dependent toxicity to mouse bone marrow cells. After a 24-h exposure to 1,4-BQ at final concentrations of 0, 0.1, 1, and 10 mu mol/L, the mRNA expression of p15 and p16 decreased with the increase in 1,4-BQ concentration. The BSP results gathered from the exposure and the control groups were the same. In summary, despite the observation that short-term exposure to 1,4-BQ primary cultivated mouse bone marrow cells decreased the p15 and p16 transcripts, with no influence by their gene promoter methylation.
引用
收藏
页码:718 / 725
页数:8
相关论文
共 47 条
  • [31] NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells
    Siegel, D
    Ryder, J
    Ross, D
    TOXICOLOGY LETTERS, 2001, 125 (1-3) : 93 - 98
  • [32] Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells
    Meng, Chun-Feng
    Zhu, Xin-Jiang
    Peng, Guo
    Dai, Dong-Qiu
    ONCOLOGY REPORTS, 2009, 22 (05) : 1221 - 1227
  • [33] Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue
    Cavusoglu, A. Celebiler
    Sevinc, A. I.
    Saydam, S.
    Canda, T.
    Baskan, Z.
    Kilic, Y.
    Sakizli, M.
    NEOPLASMA, 2010, 57 (05) : 465 - 472
  • [34] Methylation and mRNA expression levels of P15, death-associated protein kinase, and suppressor of cytokine signaling-1 genes in multiple myeloma
    Liu, Lin
    Tan, Lin
    He, Zhenxin
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (07) : 755 - 762
  • [35] NF-κB Signaling Is Increased in HD3 Cells Following Exposure to 1,4-Benzoquinone: Role of Reactive Oxygen Species and p38-MAPK
    Stokes, Samantha E.
    Winn, Louise M.
    TOXICOLOGICAL SCIENCES, 2014, 137 (02) : 303 - 310
  • [36] Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis
    Chen, Cheng
    Zhu, Ying
    Zhang, Haibo
    Xiao, Lan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (05) : 363 - 375
  • [37] Inactivation of the cyclin-dependent kinase inhibitor p15(INK4b) by deletion and de novo methylation with independence of p16(INK4 alpha) alterations in murine primary T-cell lymphomas
    Malumbres, M
    Perez de Castro, I
    Santos, J
    Melendez, B
    Mangues, R
    Serrano, M
    Pellicer, A
    FernandezPiqueras, J
    ONCOGENE, 1997, 14 (11) : 1361 - 1370
  • [38] Association of GSTP1 and P16 promoter methylation with the risk of H BV-related hepatocellular carcinoma: a meta-analysis
    Li, Qin
    Deng, Cunliang
    Zhang, Ting
    Li, Xiang
    ONCOTARGETS AND THERAPY, 2018, 11 : 5789 - 5796
  • [39] Aberrant methylation of p16, HIC1, N33, and GSTP1 in tumor epithelium and tumor-associated cells in prostate cancer
    T. V. Kekeeva
    O. P. Popova
    P. V. Shegai
    B. Ya. Alekseev
    Yu. Yu. Andreeva
    D. V. Zaletaev
    M. V. Nemtsova
    Molecular Biology, 2007, 41 : 70 - 76
  • [40] Aberrant methylation of p16, HIC1, N33, and GSTP1 in tumor epithelium and tumor-associated cells in prostate cancer
    Kekeeva, T. V.
    Popova, O. P.
    Shegai, P. V.
    Alekseev, B. Ya.
    Andreeva, Yu. Yu.
    Zaletaev, D. V.
    Nemtsova, M. V.
    MOLECULAR BIOLOGY, 2007, 41 (01) : 70 - 76